Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Merino Website

Maria J. Merino, M.D.

Selected Publications

1)  Merino M.
Hereditary leiomyomatosis and renal cell cancer.
Orphanet. 2014.
In Press. [Journal]
2)  Zhang L, Gaskins K, Yu Z, Xiong Y, Merino MJ, Kebebew E.
An in vivo mouse model of metastatic human thyroid cancer.
Thyroid. 24: 695-704, 2014.
[Journal]
3)  Logan JK, Walton-Diaz A, Rais-Bahrami S, Merino MJ, Turkbey B, Choyke PL, Pinto PA.
Changes observed in multiparametric prostate magnetic resonance imaging characteristics correlate with histopathological development of chronic granulomatous prostatitis after intravesical Bacillus Calmette-Guerin therapy.
J Comput Assist Tomogr. 38: 274-6, 2014.
[Journal]
4)  Hong CW, Rais-Bahrami S, Walton-Diaz A, Shakir N, Su D, George AK, Merino MJ, Turkbey B, Choyke PL, Wood BJ, Pinto PA.
Comparison of MR-US fusion-guided prostate biopsies obtained from axial and sagittal approaches.
BJU Int. 2014.
[Journal]
5)  Shuch B, Vourganti S, Ricketts CJ, Middleton L, Peterson J, Merino MJ, Metwalli AR, Srinivasan R, Linehan WM.
Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management.
J. Clin. Oncol. 32: 431-7, 2014.
[Journal]
6)  Rais-Bahrami S, Siddiqui MM, Vourganti S, Turkbey B, Rastinehad AR, Stamatakis L, Truong H, Walton-Diaz A, Hoang AN, Nix JW, Merino MJ, Wood BJ, Simon RM, Choyke PL, Pinto PA.
Diagnostic Value of Biparametric MRI as an Adjunct to PSA-based Detection of Prostate Cancer in Men without Prior Biopsies.
BJU Int. [Epub ahead of print], 2014.
[Journal]
7)  Ellis RJ, Wang Y, Stevenson HS, Boufraqech M, Patel D, Nilubol N, Davis S, Edelman DC, Merino MJ, He M, Zhang L, Meltzer PS, Kebebew E.
Genome-wide methylation patterns in papillary thyroid cancer are distinct based on histological subtype and tumor genotype.
J. Clin. Endocrinol. Metab. 99: E329-37, 2014.
[Journal]
8)  Farsaci B, Jochems C, Grenga I, Donahue RN, Tucker JA, Pinto PA, Merino MJ, Heery CR, Madan RA, Gulley JL, Schlom J.
Identification by digital immunohistochemistry of intratumoral changes of immune infiltrates after vaccine in the absence of modifications of PBMC immune cell subsets.
Int. J. Cancer. [Epub ahead of print], 2014.
[Journal]
9)  Hong CW, Walton-Diaz A, Rais-Bahrami S, Hoang AN, Türkbey B, Stamatakis L, Xu S, Amalou H, Siddiqui MM, Nix JW, Vourganti S, Merino MJ, Choyke PL, Wood BJ, Pinto PA.
Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session.
Diagn Interv Radiol. [Epub ahead of print], 2014.
[Journal]
10)  Turkbey B, Mena E, Shih J, Pinto PA, Merino MJ, Lindenberg ML, Bernardo M, McKinney YL, Adler S, Owenius R, Choyke PL, Kurdziel KA.
Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis.
Radiology. 270: 849-56, 2014.
[Journal]
11)  Alimchandani M, Lara K, Tsokos M, Linehan WM, Merino MJ.
Lymphangitic retroperitoneal carcinomatosis occurring from metastatic sarcomatoid chromophobe renal cell carcinoma.
Urol Case Rep. 2: 39-62, 2014.
[Journal]
12)  Boufraqech M, Zhang L, Jain M, Patel D, Ellis R, Xiong Y, He M, Nilubol N, Merino M, Kebebew E.
miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3.
Endocr. Relat. Cancer. [Epub ahead of print], 2014.
[Journal]
13)  Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ, Bottaro DP, Srinivasan R, Linehan WM.
Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.
Nat Rev Urol. 2014.
[Journal]
14)  Raskolnikov D, George AK, Rais-Bahrami S, Turkbey B, Shakir NA, Okoro C, Rothwax JT, Walton-Diaz A, Siddiqui MM, Su D, Stamatakis L, Merino MJ, Wood BJ, Choyke PL, Pinto P.
Multiparametric Magnetic Resonance Imaging and Image-Guided Biopsy to Detect Seminal Vesicle Invasion by Prostate Cancer.
J. Endourol. 2014.
[Journal]
15)  Johnson LM, Rothwax JT, Turkbey B, Rais-Bahrami S, Wood BJ, Figg WD, Choyke PL, Merino MJ, Pinto PA.
Multiparametric Magnetic Resonance Imaging of the Prostate Aids to Detect Lesion Progression.
J Comput Assist Tomogr. [Epub ahead of print], 2014.
[Journal]
16)  Rais-Bahrami S, Türkbey B, Rastinehad AR, Walton-Diaz A, Hoang AN, Siddiqui MM, Stamatakis L, Truong H, Nix JW, Vourganti S, Grant KB, Merino MJ, Choyke PL, Pinto PA.
Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up.
Diagn Interv Radiol. 20: 293-8, 2014.
[Journal]
17)  Shuch B, Hofmann JN, Merino MJ, Nix JW, Vourganti S, Linehan WM, Schwartz K, Ruterbusch JJ, Colt JS, Purdue MP, Chow W.
Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program.
Urol. Oncol. 32: 23.e9-13, 2014.
[Journal]
18)  Diker-Cohen T, Abraham SB, Rauschecker M, Papadakis GZ, Munir KM, Brown E, Lyssikatos C, Belyavskaya E, Merino M, Stratakis CA.
RENINOMA PRESENTING IN PREGNANCY.
J. Clin. Endocrinol. Metab. jc20141730, 2014.
[Journal]
19)  Shuch B, Agochukwu N, Ricketts CJ, Vocke CD, Gautam R, Merino M, Linehan WM, Srinivasan R.
Vascular Endothelial Growth Factor Receptor-Targeted Therapy in Succinate Dehydrogenase C Kidney Cancer.
J. Clin. Oncol. 2014.
[Journal]
20)  Shuch B, Ricketts CJ, Vocke CD, Valera VA, Chen CC, Gautam R, Gupta GN, Gomez Macias GS, Merino MJ, Bratslavsky G, Linehan WM.
Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer.
J. Urol. 189: 430-5, 2013.
[Journal]
21)  Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL, Bencko V, Davis FG, Graubard BI, Janout V, Ruterbusch JJ, Beebe-Dimmer J, Cote ML, Shuch B, Mates D, Hofmann JN, Foretova L, Rothman N, Szeszenia-Dabrowska N, Matveev V, Wacholder S, Zaridze D, Linehan WM, Brennan P, Chow WH.
An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies.
Int. J. Cancer. 132: 2640-7, 2013.
[Journal]
22)  Bodogai M, Lee Chang C, Wejksza K, Lai J, Merino M, Wersto RP, Gress RE, Chan AC, Hesdorffer C, Biragyn A.
Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L.
Cancer Res. 73: 2127-38, 2013.
[Journal]
23)  Walton-Diaz A, Hoang AN, Turkbey B, Hong CW, Truong H, Sterling T, Rais-Bahrami S, Siddiqui MM, Stamatakis L, Vourganti S, Nix J, Logan J, Harris C, Weintraub M, Chua C, Merino MJ, Choyke P, Wood BJ, Pinto PA.
Can MR-US Fusion Biopsy Improve Cancer Detection in Enlarged Prostates?.
J. Urol. 190: 2020-5, 2013.
[Journal]
24)  Ward Y, Lake R, Martin PL, Killian K, Salerno P, Wang T, Meltzer P, Merino M, Cheng S, Santoro M, Garcia-Rostan G, Kelly K.
CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model.
Oncogene. 32: 2726-38, 2013.
[Journal]
25)  Turkbey B, Merino MJ, Gallardo EC, Shah V, Aras O, Bernardo M, Mena E, Daar D, Rastinehad AR, Linehan WM, Wood BJ, Pinto PA, Choyke PL.
Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole-mount histopathology.
J Magn Reson Imaging. [Epub ahead of print], 2013.
[Journal]
26)  Walter BA, Valera VA, Pinto PA, Merino MJ.
Comprehensive microRNA Profiling of Prostate Cancer.
J Cancer. 4: 350-7, 2013.
[Journal]
27)  Turkbey B, Fotin SV, Huang RJ, Yin Y, Daar D, Aras O, Bernardo M, Garvey BE, Weaver J, Haldankar H, Muradyan N, Merino MJ, Pinto PA, Periaswamy S, Choyke PL.
Fully automated prostate segmentation on MRI: comparison with manual segmentation methods and specimen volumes.
AJR Am J Roentgenol. 201: W720-9, 2013.
[Journal]
28)  Farley MN, Schmidt LS, Mester JL, Pena-Llopis S, Pavia-Jimenez A, Christie A, Vocke CD, Ricketts CJ, Peterson J, Middelton L, Kinch L, Grishin N, Merino MJ, Metwalli AR, Xing C, Xie X, Dahia PL, Eng C, Linehan WM, Brugarolas J.
Germline BAP1 mutation predisposes to familial clear-cell renal cell carcinoma.
Mol. Cancer Res. 11: 1061-71, 2013.
[Journal]
29)  Shuch B, Ricketts CJ, Vocke CD, Komiya T, Middelton LA, Kauffman EC, Merino MJ, Metwalli AR, Dennis P, Linehan WM.
Germline PTEN Mutation Cowden Syndrome: An Under-Appreciated Form of Hereditary Kidney Cancer.
J. Urol. 190: 1990-8, 2013.
[Journal]
30)  Liu NW, Sanford T, Srinivasan R, Liu JL, Khurana K, Aprelikova O, Valero V, Bechert C, Worrell R, Pinto PA, Yang Y, Merino M, Linehan WM, Bratslavsky G.
Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma.
Clin. Cancer Res. 19: 42-9, 2013.
[Journal]
31)  Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA.
Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy Significantly Upgrades Prostate Cancer Versus Systematic 12-core Transrectal Ultrasound Biopsy.
Eur Urol. 64: 713-9, 2013.
[Journal]
32)  Sanz-Ortega J, Vocke C, Stratton P, Linehan WM, Merino MJ.
Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.
Am. J. Surg. Pathol. 37: 74-80, 2013.
[Journal]
33)  Pacak K, Jochmanova I, Prodanov T, Yang C, Merino MJ, Fojo T, Prchal JT, Tischler AS, Lechan RM, Zhuang Z.
New Syndrome of Paraganglioma and Somatostatinoma Associated With Polycythemia.
J. Clin. Oncol. 31: 1690-8, 2013.
[Journal]
34)  Gulley JL, Heery CR, Madan RA, Walter BA, Merino MJ, Dahut WL, Tsang KY, Schlom J, Pinto PA.
Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer.
Cancer Immunol. Immunother. 62: 1521-31, 2013.
[Journal]
35)  Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM, Rini BI, Srinivas S, Stein MN, Adams LM, Ottesen LH, Laubscher KH, Sherman L, McDermott DF, Haas NB, Flaherty KT, Ross R, Eisenberg P, Meltzer PS, Merino MJ, Bottaro DP, Linehan WM, Srinivasan R.
Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma.
J. Clin. Oncol. 31: 181-6, 2013.
[Journal]
36)  Aung PP, Killian K, Poropatich CO, Linehan WM, Merino MJ.
Primary neuroendocrine tumors of the kidney: morphological and molecular alterations of an uncommon malignancy.
Hum. Pathol. 44: 873-80, 2013.
[Journal]
37)  Sadowski SM, He M, Gesuwan K, Gulati N, Celi F, Merino MJ, Nilubol N, Kebebew E.
Prospective screening in familial nonmedullary thyroid cancer.
Surgery. 154: 1194-8, 2013.
[Journal]
38)  Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad AR, Agarwal H, Shah V, Bernardo M, Pang Y, Daar D, McKinney YL, Linehan WM, Kaushal A, Merino MJ, Wood BJ, Pinto PA, Choyke PL.
Prostate Cancer: Can Multiparametric MR Imaging Help Identify Patients Who Are Candidates for Active Surveillance?.
Radiology. 268: 144-52, 2013.
[Journal]
39)  Liu Q, Galli S, Srinivasan R, Linehan WM, Tsokos M, Merino MJ.
Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation.
Am. J. Surg. Pathol. 37: 368-74, 2013.
[Journal]
40)  Tan PH, Cheng L, Rioux-Leclercq N, Merino MJ, Netto G, Reuter VE, Shen SS, Grignon DJ, Montironi R, Egevad L, Srigley JR, Delahunt B, Moch H.
Renal tumors: diagnostic and prognostic biomarkers.
Am. J. Surg. Pathol. 37: 1518-31, 2013.
[Journal]
41)  Zucali PA, Di Tommaso L, Petrini I, Battista S, Lee HS, Merino M, Lorenzi E, Voulaz E, De Vincenzo F, Simonelli M, Roncalli M, Giordano L, Alloisio M, Santoro A, Giaccone G.
Reproducibility of the WHO classification of thymomas: practical implications.
Lung Cancer. 79: 236-41, 2013.
[Journal]
42)  Price JC, Pollock LM, Rudd ML, Fogoros SK, Mohamed H, Hanigan CL, Le Gallo M, Program NI, Zhang S, Cruz P, Cherukuri PF, Hansen NF, McManus KJ, Godwin AK, Sgroi DC, Mullikin JC, Merino MJ, Hieter P, Bell DW.
Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A.
PLoS ONE. 8: e63313, 2013.
[Journal]
43)  Killian JK, Kim SY, Miettinen M, Smith C, Merino M, Tsokos M, Quezado M, Smith WI, Jahromi MS, Xekouki P, Szarek E, Walker R, Lasota J, Raffeld M, Klotzle B, Wang Z, Jones L, Zhu YJ, Wang Y, Waterfall J, O'Sullivan M, Bibikova M, Pacak K, Stratakis CA, Janeway KA, Schiffman JD, Fan J, Helman LJ, Meltzer PS.
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor.
Cancer Discov. 268: 144-52, 2013.
[Journal]
44)  Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN, Walton-Diaz A, Vourganti S, Truong H, Kruecker J, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Usefulness of Multiparametric Magnetic Resonance Imaging Suspicion Levels in Detecting Prostate Cancer.
J. Urol. 190: 1721-7, 2013.
[Journal]
45)  Fox E, Widemann BC, Chuk MK, Marcus L, Aikin A, Whitcomb PO, Merino MJ, Lodish M, Dombi E, Steinberg SM, Wells SA, Balis FM.
Vandetanib in Children and Adolescents with Multiple Endocrine Neoplasia Type 2B Associated Medullary Thyroid Carcinoma.
Clin. Cancer Res. 19: 4239-48, 2013.
[Journal]
46)  Zhong M, Weisman P, Zhu B, Brassesco M, Yang Y, Linehan WM, Merino MJ, Zhang D, Rohan S, Cai D, Yang X.
Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangement.
Diagn. Mol. Pathol. 22: 107-11, 2013.
[Journal]
47)  Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA.
11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.
J. Nucl. Med. 53: 538-45, 2012.
[Journal]
48)  Rahma OE, Ashtar E, Czystowska M, Szajnik ME, Wieckowski E, Bernstein S, Herrin VE, Shams MA, Steinberg SM, Merino M, Gooding W, Visus C, Deleo AB, Wolf JK, Bell JG, Berzofsky JA, Whiteside TL, Khleif SN.
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients.
Cancer Immunol. Immunother. 61: 373-84, 2012.
[Journal]
49)  Yang Y, Valera V, Sourbier C, Vocke CD, Wei M, Pike L, Huang Y, Merino MA, Bratslavsky G, Wu M, Ricketts CJ, Linehan WM.
A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer.
Cancer Genet. 205: 377-90, 2012.
[Journal]
50)  Nogales FF, Goyenaga P, Preda O, Nicolae A, Vieites B, Ruiz-Marcellan MC, Pedrosa A, Merino MJ.
An analysis of five clear cell papillary cystadenomas of mesosalpinx and broad ligament: four associated with von Hippel-Lindau disease and one aggressive sporadic type.
Histopathology. 60: 748-57, 2012.
[Journal]
51)  Boyce AM, Chong WH, Shawker TH, Pinto PA, Linehan WM, Bhattacharryya N, Merino MJ, Singer FR, Collins MT.
Characterization and Management of Testicular Pathology in McCune-Albright Syndrome.
J. Clin. Endocrinol. Metab. 97: E1782-90, 2012.
[Journal]
52)  Turkbey B, Mani H, Aras O, Rastinehad AR, Shah V, Bernardo M, Pohida T, Daar D, Benjamin C, McKinney YL, Linehan WM, Wood BJ, Merino MJ, Choyke PL, Pinto PA.
Correlation of Magnetic Resonance Imaging Tumor Volume with Histopathology.
J. Urol. 188: 1157-63, 2012.
[Journal]
53)  Shah V, Turkbey B, Mani H, Pang Y, Pohida T, Merino MJ, Pinto PA, Choyke PL, Bernardo M.
Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging.
Med Phys. 39: 4093-103, 2012.
[Journal]
54)  Kuhn E, Teller L, Piana S, Rosai J, Merino MJ.
Different clonal origin of bilateral papillary thyroid carcinoma, with a review of the literature.
Endocr. Pathol. 23: 101-7, 2012.
[Journal]
55)  Rechache NS, Wang Y, Stevenson HS, Killian JK, Edelman DC, Merino M, Zhang L, Nilubol N, Stratakis CA, Meltzer PS, Kebebew E.
DNA Methylation Profiling Identifies Global Methylation Differences and Markers of Adrenocortical Tumors.
J. Clin. Endocrinol. Metab. 97: E1004-13, 2012.
[Journal]
56)  Butler PW, Cochran CS, Merino MJ, Nguyen DM, Schrump DS, Gorden P.
Ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumor: clinical experience following tumor resection and long-acting octreotide therapy.
Pituitary. 15: 260-5, 2012.
[Journal]
57)  Kalra N, Zhang J, Yu Y, Ho M, Merino M, Cao L, Hassan R.
Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell.
Int. J. Cancer. 131: 2143-52, 2012.
[Journal]
58)  Ziadloo A, Burks SR, Gold EM, Lewis BK, Chaudhry A, Merino MJ, Frenkel V, Frank JA.
Enhanced homing permeability and retention of bone marrow stromal cells by noninvasive pulsed focused ultrasound.
Stem Cells. 30: 1216-27, 2012.
[Journal]
59)  Le Gallo M, O'Hara AJ, Rudd ML, Urick ME, Hansen NF, O'Neil NJ, Price JC, Zhang S, England BM, Godwin AK, Sgroi DC, Hieter P, Mullikin JC, Merino MJ, Bell DW.
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes.
Nat. Genet. 44: 1310-5, 2012.
[Journal]
60)  Moore LE, Jaeger E, Nickerson ML, Brennan P, De Vries S, Roy R, Toro J, Li H, Karami S, Lenz P, Zaridze D, Janout V, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Linehan WM, Merino M, Simko J, Pfeiffer R, Boffetta P, Hewitt S, Rothman N, Chow WH, Waldman FM.
Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation.
Oncogenesis. 1: e14, 2012.
[Journal]
61)  Pang Y, Turkbey B, Bernardo M, Kruecker J, Kadoury S, Merino MJ, Wood BJ, Pinto PA, Choyke PL.
Intravoxel incoherent motion MR imaging for prostate cancer: An evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations.
Magn. Reson. Med. 69: 553-62, 2012.
[Journal]
62)  Zhang J, Qiu S, Zhang Y, Merino M, Fetsch P, Avital I, Filie A, Pastan I, Hassan R.
Loss of mesothelin expression by mesothelioma cells grown in vitro determines sensitivity to anti-mesothelin immunotoxin SS1P.
Anticancer Res. 32: 5151-8, 2012.
[Journal]
63)  Posligua L, Silva EG, Deavers MT, Merino MJ, Malpica A.
Low-grade smooth muscle tumors of the primary and the secondary mullerian system: a proposed concept of multicentricity.
Int. J. Gynecol. Pathol. 31: 547-55, 2012.
[Journal]
64)  Venkatesan AM, Partanen A, Pulanic TK, Dreher MR, Fischer J, Zurawin RK, Muthupillai R, Sokka S, Nieminen HJ, Sinaii N, Merino M, Wood BJ, Stratton P.
Magnetic Resonance Imaging-guided Volumetric Ablation of Symptomatic Leiomyomata: Correlation of Imaging with Histology.
J Vasc Interv Radiol. 23: 786-794.e4, 2012.
[Journal]
65)  Zhuang Z, Yang C, Lorenzo F, Merino M, Fojo T, Kebebew E, Popovic V, Stratakis CA, Prchal JT, Pacak K.
Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia.
N. Engl. J. Med. 367: 922-30, 2012.
[Journal]
66)  Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, Stolle CA, Zbar B, Merino MJ, Schmidt LS, Pinto PA, Srinivasan R, Pacak K, Linehan WM.
Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer.
J. Urol. 188: 2063-71, 2012.
[Journal]
67)  Zhong M, De Angelo P, Osborne L, Paniz-Mondolfi AE, Geller M, Yang Y, Linehan WM, Merino MJ, Cordon-Cardo C, Cai D.
Translocation renal cell carcinomas in adults: a single-institution experience.
Am. J. Surg. Pathol. 36: 654-62, 2012.
[Journal]
68)  Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA.
Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer.
Urology. 79: 233-9, 2012.
[Journal]
69)  Rudd ML, Price JC, Fogoros S, Godwin AK, Sgroi DC, Merino MJ, Bell DW.
A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas.
Clin. Cancer Res. 17: 1331-40, 2011.
[Journal]
70)  Gannot G, Richardson AM, Rodriguez-Canales J, Pinto PA, Merino MJ, Chuaqui RF, Gillespie JW, Emmert-Buck MR.
Decrease in CD8+ lymphocyte number and altered cytokine profile in human prostate cancer.
Am J Cancer Res. 1: 120-127, 2011.
[Journal]
71)  Bratslavsky G, Sanford T, Srinivasan R, Aprelikova O, Liu J, Quezado M, Merino M, Linehan WM.
Differential genetic expression in large versus small clear cell renal cell carcinoma: results from microarray analysis.
J Cancer. 2: 271-9, 2011.
[Journal]
72)  Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Shah V, Bernardo M, Baccala A, Rastinehad A, Benjamin C, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI.
Cancer Imaging. 11: 31-6, 2011.
[Journal]
73)  Schwartzentruber DJ, Lawson DH, Richards JM, Conry RM, Miller DM, Treisman J, Gailani F, Riley L, Conlon K, Pockaj B, Kendra KL, White RL, Gonzalez R, Kuzel TM, Curti B, Leming PD, Whitman ED, Balkissoon J, Reintgen DS, Kaufman H, Marincola FM, Merino MJ, Rosenberg SA, Choyke P, Vena D, Hwu P.
gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.
N. Engl. J. Med. 364: 2119-27, 2011.
[Journal]
74)  Cherkasova E, Malinzak E, Rao S, Takahashi Y, Senchenko VN, Kudryavtseva AV, Nickerson ML, Merino M, Hong JA, Schrump DS, Srinivasan R, Linehan WM, Tian X, Lerman MI, Childs RW.
Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer.
Oncogene. 30: 4697-706, 2011.
[Journal]
75)  Turkbey B, Shah VP, Pang Y, Bernardo M, Xu S, Kruecker J, Locklin J, Baccala AA, Rastinehad AR, Merino MJ, Shih JH, Wood BJ, Pinto PA, Choyke PL.
Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?.
Radiology. 258: 488-95, 2011.
[Journal]
76)  Ward Y, Lake R, Yin JJ, Heger CD, Raffeld M, Goldsmith PK, Merino M, Kelly K.
LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.
Cancer Res. 71: 7301-11, 2011.
[Journal]
77)  Zelinka T, Musil Z, Dušková J, Burton D, Merino MJ, Milosevic D, Widimský J, Pacak K.
Metastatic pheochromocytoma: Does the size and age matter?.
Eur. J. Clin. Invest. 41: 1121-8, 2011.
[Journal]
78)  Walter BA, Gómez-Macias G, Valera VA, Sobel M, Merino MJ.
miR-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor Prognosis.
J Cancer. 2: 67-75, 2011.
[Journal]
79)  Valera VA, Merino MJ.
Misdiagnosis of clear cell renal cell carcinoma.
Nat Rev Urol. 8: 321-33, 2011.
[Journal]
80)  Türkbey B, Bernardo M, Merino MJ, Wood BJ, Pinto PA, Choyke PL.
MRI of localized prostate cancer: coming of age in the PSA era.
Diagn Interv Radiol. 18: 34-45, 2011.
[Journal]
81)  Turkbey B, Mani H, Shah V, Rastinehad AR, Bernardo M, Pohida T, Pang Y, Daar D, Benjamin C, McKinney YL, Trivedi H, Chua C, Bratslavsky G, Shih JH, Linehan WM, Merino MJ, Choyke PL, Pinto PA.
Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.
J. Urol. 186: 1818-24, 2011.
[Journal]
82)  Urick ME, Rudd ML, Godwin AK, Sgroi D, Merino M, Bell DW.
PIK3R1 (p85{alpha}) Is Somatically Mutated at High Frequency in Primary Endometrial Cancer.
Cancer Res. 71: 4061-7, 2011.
[Journal]
83)  Bell DW, Sikdar N, Lee KY, Price JC, Chatterjee R, Park HD, Fox J, Ishiai M, Rudd ML, Pollock LM, Fogoros SK, Mohamed H, Hanigan CL, Zhang S, Cruz P, Renaud G, Hansen NF, Cherukuri PF, Borate B, McManus KJ, Stoepel J, Sipahimalani P, Godwin AK, Sgroi DC, Merino MJ, Elliot G, Elkahloun A, Vinson C, Takata M, Mullikin JC, Wolfsberg TG, Hieter P, Lim DS, Myung K.
Predisposition to cancer caused by genetic and functional defects of mammalian Atad5.
PLoS Genet. 7: e1002245, 2011.
[Journal]
84)  Valera VA, Walter BA, Linehan WM, Merino MJ.
Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma.
J Cancer. 2: 515-26, 2011.
[Journal]
85)  Parkhurst MR, Yang JC, Langan RC, Dudley ME, Nathan DA, Feldman SA, Davis JL, Morgan RA, Merino MJ, Sherry RM, Hughes MS, Kammula US, Phan GQ, Lim RM, Wank SA, Restifo NP, Robbins PF, Laurencot CM, Rosenberg SA.
T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.
Mol. Ther. 19: 620-6, 2011.
[Journal]
86)  Boris RS, Benhammou J, Merino M, Pinto PA, Linehan WM, Bratslavsky G.
The Impact of Germline BHD Mutation on Histological Concordance and Clinical Treatment of Patients With Bilateral Renal Masses and Known Unilateral Oncocytoma.
J. Urol. 185: 2050-5, 2011.
[Journal]
87)  Moore LE, Nickerson ML, Brennan P, Toro JR, Jaeger E, Rinsky J, Han SS, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Schmidt LS, Lenz P, Karami S, Linehan WM, Merino M, Chanock S, Boffetta P, Chow WH, Waldman FM, Rothman N.
Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors.
PLoS Genet. 7: e1002312, 2011.
[Journal]
88)  Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Bernardo M, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Documenting the location of prostate biopsies with image fusion.
BJU Int. 107: 53-7, 2010.
[Journal]
89)  Zhong M, De Angelo P, Osborne L, Keane-Tarchichi M, Goldfischer M, Edelmann L, Yang Y, Linehan WM, Merino MJ, Aisner S, Hameed M.
Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma.
Am. J. Surg. Pathol. 34: 757-66, 2010.
[Journal]
90)  Stratton P, Levens ED, Hartog B, Piquion J, Wei Q, Merino M, Nieman LK.
Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914.
Fertil. Steril. 93: 2035-41, 2010.
[Journal]
91)  Jiang L, Malpica A, Deavers MT, Guo M, Villa LL, Nuovo G, Merino MJ, Silva EG.
Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
Int. J. Gynecol. Pathol. 29: 146-56, 2010.
[Journal]
92)  Wolff EF, Hughes M, Merino MJ, Reynolds JC, Davis JL, Cochran CS, Celi FS.
Expression of Benign and Malignant Thyroid Tissue in Ovarian Teratomas and the Importance of Multimodal Management as Illustrated by a BRAF-Positive Follicular Variant of Papillary Thyroid Cancer.
Thyroid. 20: 981-7, 2010.
[Journal]
93)  Zucali PA, Petrini I, Lorenzi E, Merino M, Cao L, Di Tommaso L, Lee HS, Incarbone M, Walter BA, Simonelli M, Roncalli M, Santoro A, Giaccone G.
Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas.
Cancer. 116: 4686-95, 2010.
[Journal]
94)  Lodish MB, Gartner LA, Albini P, Sabnis G, Brodie A, Meck JM, Meloni-Ehrig AM, Hill S, Tsilou E, Valera VA, Walter BA, Merino MJ, Stratakis CA.
Intrauterine growth retardation associated with precocious puberty and sertoli cell hyperplasia.
Horm. Metab. Res. 42: 682-8, 2010.
[Journal]
95)  Wagner M, Browne HN, Marston Linehan W, Merino M, Babar N, Stratton P.
Lipid cell tumors in two women with von Hippel-Lindau syndrome.
Obstet Gynecol. 116 Suppl 2: 535-9, 2010.
[Journal]
96)  Merino MJ.
Malignant mesothelioma mimicking ovarian cancer.
Int. J. Surg. Pathol. 18: 178S-180S, 2010.
[Journal]
97)  Mani H, Merino MJ.
Mesothelial neoplasms presenting as, and mimicking, ovarian cancer.
Int. J. Gynecol. Pathol. 29: 523-8, 2010.
[Journal]
98)  Moore LE, Boffetta P, Karami S, Brennan P, Stewart PS, Hung R, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Gromiec J, Holcatova I, Merino M, Chanock S, Chow WH, Rothman N.
Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants.
Cancer Res. 70: 6527-36, 2010.
[Journal]
99)  Kummar S, Gutierrez ME, Gardner ER, Chen X, Figg WD, Zajac-Kaye M, Chen M, Steinberg SM, Muir CA, Yancey MA, Horneffer YR, Juwara L, Melillo G, Ivy SP, Merino M, Neckers L, Steeg PS, Conley BA, Giaccone G, Doroshow JH, Murgo AJ.
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies.
Eur. J. Cancer. 46: 340-7, 2010.
[Journal]
100)  Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL, Khurana K, Ravizzini GC, Albert PS, Merino MJ, Choyke PL.
Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.
Radiology. 255: 89-99, 2010.
[Journal]
101)  Valera VA, Li-Ning-T E, Walter BA, Roberts DD, Linehan WM, Merino MJ.
Protein expression profiling in the spectrum of renal cell carcinomas.
J Cancer. 1: 184-96, 2010.
[Journal]
102)  McDermott NE, Barrett J, Hipp J, Merino MJ, Richard Lee CC, Waterman P, Domingo DL, Walsh TJ.
Successful treatment of periodontal mucormycosis: report of a case and literature review.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 109: e64-9, 2010.
[Journal]
103)  Lodish MB, Adams KT, Huynh TT, Prodanov T, Ling A, Chen C, Shusterman S, Jimenez C, Merino M, Hughes M, Cradic KW, Milosevic D, Singh RJ, Stratakis CA, Pacak K.
Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl.
Endocr. Relat. Cancer. 17: 581-8, 2010.
[Journal]
104)  Hong SB, Oh H, Valera VA, Stull J, Ngo DT, Baba M, Merino MJ, Linehan WM, Schmidt LS.
Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signaling.
Mol. Cancer. 9: 160, 2010.
[Journal]
105)  Fliedner SM, Breza J, Kvetnansky R, Powers JF, Tischler AS, Wesley R, Merino M, Lehnert H, Pacak K.
Tyrosine hydroxylase, chromogranin A, and steroidogenic acute regulator as markers for successful separation of human adrenal medulla.
Cell Tissue Res. 340: 607-12, 2010.
[Journal]
106)  Yang Y, Valera VA, Padilla-Nash HM, Sourbier C, Vocke CD, Vira MA, Abu-Asab MS, Bratslavsky G, Tsokos M, Merino MJ, Pinto PA, Srinivasan R, Ried T, Neckers L, Linehan WM.
UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer.
Cancer Genet. Cytogenet. 196: 45-55, 2010.
[Journal]
107)  Merino MJ.
What is new in renal pathology?.
Int. J. Surg. Pathol. 18: 98S-100S, 2010.
[Journal]
108)  Shah V, Pohida T, Turkbey B, Mani H, Merino M, Pinto PA, Choyke P, Bernardo M.
A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds.
Rev Sci Instrum. 80: 104301, 2009.
[Journal]
109)  Palmieri D, Fitzgerald D, Shreeve SM, Hua E, Bronder JL, Weil RJ, Davis S, Stark AM, Merino MJ, Kurek R, Mehdorn HM, Davis G, Steinberg SM, Meltzer PS, Aldape K, Steeg PS.
Analyses of Resected Human Brain Metastases of Breast Cancer Reveal the Association between Up-Regulation of Hexokinase 2 and Poor Prognosis.
Mol Cancer Res. 7: 1438-45, 2009.
[Journal]
110)  Martiniova L, Lai EW, Thomasson D, Kiesewetter DO, Seidel J, Merino MJ, Kvetnansky R, Pacak K.
Animal model of metastatic pheochromocytoma: evaluation by MRI and PET.
Endocr Regul. 43: 59-64, 2009.
[Journal]
111)  Horvath A, Korde L, Greene MH, Libe R, Osorio P, Faucz FR, Raffin-Sanson ML, Tsang KM, Drori-Herishanu L, Patronas Y, Remmers EF, Nikita ME, Moran J, Greene J, Nesterova M, Merino M, Bertherat J, Stratakis CA.
Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors.
Cancer Res. 69: 5301-6, 2009.
[Journal]
112)  Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro D, Neckers L, Schmidt LS, Srinivasan R.
Hereditary kidney cancer: unique opportunity for disease-based therapy.
Cancer. 115: 2252-61, 2009.
[Journal]
113)  Hasumi Y, Baba M, Ajima R, Hasumi H, Valera VA, Klein ME, Haines DC, Merino MJ, Hong SB, Yamaguchi TP, Schmidt LS, Linehan WM.
Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2.
Proc. Natl. Acad. Sci. U.S.A. 106: 18722-7, 2009.
[Journal]
114)  Mukherjee S, Richardson AM, Rodriguez-Canales J, Ylaya K, Erickson HS, Player A, Kawasaki ES, Pinto PA, Choyke PL, Merino MJ, Albert PS, Chuaqui RF, Emmert-Buck MR.
Identification of EpCAM as a molecular target of prostate cancer stroma.
Am. J. Pathol. 175: 2277-87, 2009.
[Journal]
115)  Xie H, Valera VA, Merino MJ, Amato AM, Signoretti S, Linehan WM, Sukhatme VP, Seth P.
LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer.
Mol. Cancer Ther. 8: 626-35, 2009.
[Journal]
116)  Martiniova L, Kotys MS, Thomasson D, Schimel D, Lai EW, Bernardo M, Merino MJ, Powers JF, Ruzicka J, Kvetnansky R, Choyke PL, Pacak K.
Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI.
J Magn Reson Imaging. 29: 685-91, 2009.
[Journal]
117)  Solis DC, Burnichon N, Timmers HJ, Raygada MJ, Kozupa A, Merino MJ, Makey D, Adams KT, Venisse A, Gimenez-Roqueplo AP, Pacak K.
Penetrance and clinical consequences of a gross SDHB deletion in a large family.
Clin. Genet. 75: 354-63, 2009.
[Journal]
118)  Malek R, McCarthy-Keith D, Levens ED, Merino MJ, DeCherney AH, Weinstein LS.
A gastrointestinal stromal tumor in a patient with multiple endocrine neoplasia type 2A and metastatic medullary thyroid cancer to the ovaries.
Endocr Pract. 14: 898-901, 2008.
[Journal]
119)  Mackall CL, Rhee EH, Read EJ, Khuu HM, Leitman SF, Bernstein D, Tesso M, Long LM, Grindler D, Merino M, Kopp W, Tsokos M, Berzofsky JA, Helman LJ.
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas.
Clin. Cancer Res. 14: 4850-8, 2008.
[Journal]
120)  Stewart L, Glenn GM, Stratton P, Goldstein AM, Merino MJ, Tucker MA, Linehan WM, Toro JR.
Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.
Arch Dermatol. 144: 1584-92, 2008.
[Journal]
121)  Toro JR, Wei M, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM.
BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports.
J. Med. Genet. 45: 321-31, 2008.
[Journal]
122)  Timmers HJ, Pacak K, Huynh TT, Abu-Asab M, Tsokos M, Merino MJ, Baysal BE, Adams KT, Eisenhofer G.
Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene.
J. Clin. Endocrinol. Metab. 93: 4826-32, 2008.
[Journal]
123)  Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ.
Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference.
Diagn. Cytopathol. 36: 425-37, 2008.
[Journal]
124)  Gril B, Palmieri D, Bronder JL, Herring JM, Vega-Valle E, Feigenbaum L, Liewehr DJ, Steinberg SM, Merino MJ, Rubin SD, Steeg PS.
Effect of Lapatinib on the Outgrowth of Metastatic Breast Cancer Cells to the Brain.
J. Natl. Cancer Inst. 100: 1092-103, 2008.
[Journal]
125)  Ahmadzadeh M, Felipe-Silva A, Heemskerk B, Powell DJ, Wunderlich JR, Merino MJ, Rosenberg SA.
FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions.
Blood. 112: 4953-60, 2008.
[Journal]
126)  Finley DS, Narula N, Valera VA, Merino MJ, Fruehauf J, Wu ML, Linehan WM, Clayman RV.
Immunohistochemical basis for adjuvant anti-angiogenic targeted therapy for renal carcinoid: Initial case report.
Urol. Oncol. 29: 85-9, 2008.
[Journal]
127)  Nickerson ML, Jaeger E, Shi Y, Durocher JA, Mahurkar S, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Schmidt LS, Toro JR, Karami S, Hung R, Gerard GF, Linehan WM, Merino M, Zbar B, Boffetta P, Brennan P, Rothman N, Chow WH, Waldman FM, Moore LE.
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.
Clin. Cancer Res. 14: 4726-34, 2008.
[Journal]
128)  Layfield LJ, Abrams J, Cochand-Priollet B, Evans D, Gharib H, Greenspan F, Henry M, LiVolsi V, Merino M, Michael CW, Wang H, Wells SA.
Post-thyroid FNA testing and treatment options: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference.
Diagn. Cytopathol. 36: 442-8, 2008.
[Journal]
129)  Mutter GL, Bergeron C, Deligdisch L, Ferenczy A, Glant M, Merino M, Williams AR, Blithe DL.
The spectrum of endometrial pathology induced by progesterone receptor modulators.
Mod. Pathol. 21: 591-8, 2008.
[Journal]
130)  Yang Y, Padilla-Nash HM, Vira MA, Abu-Asab MS, Val D, Worrell R, Tsokos M, Merino MJ, Pavlovich CP, Ried T, Linehan WM, Vocke CD.
The UOK 257 cell line: a novel model for studies of the human Birt-Hogg-Dube gene pathway.
Cancer Genet. Cytogenet. 180: 100-9, 2008.
[Journal]
131)  Signoretti S, Bratslavsky G, Waldman FM, Reuter VE, Haaga J, Merino M, Thomas GV, Pins MR, Libermann T, Gillespie J, Tomaszewski JE, Compton CC, Hruszkewycz A, Linehan WM, Atkins MB.
Tissue-based research in kidney cancer: current challenges and future directions.
Clin. Cancer Res. 14: 3699-705, 2008.
[Journal]
132)  Huang H, Abraham J, Hung E, Averbuch S, Merino M, Steinberg SM, Pacak K, Fojo T.
Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation From a 22-Year Follow-up of 18 Patients.
Cancer. 113: 2020-8, 2008.
[Journal]
133)  Filie AC, Asa SL, Geisinger KR, Logani S, Merino M, Nikiforov YE, Clark DP.
Utilization of ancillary studies in thyroid fine needle aspirates: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference.
Diagn. Cytopathol. 36: 438-41, 2008.
[Journal]
134)  Mai PL, Korde L, Kramer J, Peters J, Mueller CM, Pfeiffer S, Stratakis CA, Pinto PA, Bratslavsky G, Merino M, Choyke P, Linehan WM, Greene MH.
A possible new syndrome with growth-hormone secreting pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familial testicular germ cell malignancy: A case report.
J Med Case Reports. 1: 9, 2007.
[Journal]
135)  Begnami MD, Quezado M, Pinto P, Linehan WM, Merino M.
Adenoid cystic/basal cell carcinoma of the prostate: review and update.
Arch. Pathol. Lab. Med. 131: 637-40, 2007.
[Journal]
136)  Powell DJ, Felipe-Silva A, Merino MJ, Ahmadzadeh M, Allen T, Levy C, White DE, Mavroukakis S, Kreitman RJ, Rosenberg SA, Pastan I.
Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo.
J. Immunol. 179: 4919-28, 2007.
[Journal]
137)  Zbar B, Glenn G, Merino M, Middelton L, Peterson J, Toro J, Coleman J, Pinto P, Schmidt LS, Choyke P, Linehan WM.
Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development.
J. Urol. 177: 461-5; discussion 465, 2007.
[Journal]
138)  Grubb RL, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, Torres-Cabala C, Glenn GM, Choyke P, Merino MJ, Zbar B, Pinto PA, Srinivasan R, Coleman JA, Linehan WM.
Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.
J. Urol. 177: 2074-9; discussion 2079-80, 2007.
[Journal]
139)  Rodriguez-Canales J, Hanson JC, Tangrea MA, Erickson HS, Albert PS, Wallis BS, Richardson AM, Pinto PA, Linehan WM, Gillespie JW, Merino MJ, Libutti SK, Woodson KG, Emmert-Buck MR, Chuaqui RF.
Identification of a unique epigenetic sub-microenvironment in prostate cancer.
J. Pathol. 211: 410-9, 2007.
[Journal]
140)  Linehan WM, Pinto PA, Srinivasan R, Merino M, Choyke P, Choyke L, Coleman J, Toro J, Glenn G, Vocke C, Zbar B, Schmidt LS, Bottaro D, Neckers L.
Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics.
Clin. Cancer Res. 13: 671s-679s, 2007.
[Journal]
141)  Horak CE, Mendoza A, Vega-Valle E, Albaugh M, Graff-Cherry C, McDermott WG, Hua E, Merino MJ, Steinberg SM, Khanna C, Steeg PS.
Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.
Cancer Res. 67: 11751-9, 2007.
[Journal]
142)  Palau MA, Thu Pham T, Barnard N, Merino MJ.
Primary synovial sarcoma of the kidney with rhabdoid features.
Int. J. Surg. Pathol. 15: 421-8, 2007.
[Journal]
143)  Merino MJ, Torres-Cabala C, Pinto P, Linehan WM.
The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome.
Am. J. Surg. Pathol. 31: 1578-85, 2007.
[Journal]
144)  Stegmann BJ, Sinaii N, Liu S, Segars J, Merino M, Nieman LK, Stratton P.
Using location, color, size, and depth to characterize and identify endometriosis lesions in a cohort of 133 women.
Fertil Steril. 89: 1632-6, 2007.
[Journal]
145)  Remon C, Quiros PL, Perez Banasco V, Toran D, Tejuca F, Merino MJ, Guerrero J, Ruiz A, Paez MC, Martinez E, Espigares MJ, Gonzalez L, Martin G, Castro P, Fernandez E.
[Report of the Andalusian registry of patients with end stage renal disease in treatment with peritoneal dialysis: period 1999-2004].
Nefrologia. 26: 45-55, 2006.
[Journal]
146)  Palau MA, Merino MJ, Quezado M.
Corticotropin-producing pulmonary gangliocytic paraganglioma associated with Cushing's syndrome.
Hum. Pathol. 37: 623-6, 2006.
[Journal]
147)  Castillo M, Sanjuán A, Pérez N, Zanón G, Bons N, Vilanova M, Vanrell JA, Merino MJ, Fernández PL.
Fibrous Histiocytoma-like Spindle-Cell Proliferation in the Nipple After Body-Piercing.
Int. J. Surg. Pathol. 14: 89-93, 2006.
[Journal]
148)  Schinstine M, Filie AC, Torres-Cabala C, Abati A, Linehan WM, Merino M.
Fine-needle aspiration of a Xp11.2 translocation/TFE3 fusion renal cell carcinoma metastatic to the lung: report of a case and review of the literature.
Diagn. Cytopathol. 34: 751-6, 2006.
[Journal]
149)  Torres-Cabala C, Bibbo M, Panizo-Santos A, Barazi H, Krutzsch H, Roberts DD, Merino MJ.
Proteomic identification of new biomarkers and application in thyroid cytology.
Acta Cytol. 50: 518-28, 2006.
[Journal]
150)  Palmieri D, Bouadis A, Ronchetti R, Merino MJ, Steeg PS.
Rab11a dfferentially modulates epidermal growth factor-induced proliferation and motility in immortal breast cells.
Breast Cancer Res Treat. 100: 127-37, 2006.
[Journal]
151)  Bakalov VK, Anasti JN, Calis KA, Vanderhoof VH, Premkumar A, Chen S, Furmaniak J, Smith BR, Merino MJ, Nelson LM.
Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure.
Fertil. Steril. 84: 958-65, 2005.
[Journal]
152)  Pavlovich CP, Grubb RL, Hurley K, Glenn GM, Toro J, Schmidt LS, Torres-Cabala C, Merino MJ, Zbar B, Choyke P, Walther MM, Linehan WM.
Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome.
J Urol. 173: 1482-6, 2005.
[Journal]
153)  Schmidt LS, Nickerson ML, Warren MB, Glenn GM, Toro JR, Merino MJ, Turner ML, Choyke PL, Sharma N, Peterson J, Morrison P, Maher ER, Walther MM, Zbar B, Linehan WM.
Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome.
Am J Hum Genet. 76: 1023-33, 2005.
[Journal]
154)  Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, Ratcliffe PJ, Linehan WM, Neckers L.
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability.
Cancer Cell. 8: 143-53, 2005.
[Journal]
155)  Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA, Merino MJ, Walther MM, Zbar B, Linehan WM.
High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors.
J Natl Cancer Inst. 97: 931-5, 2005.
[Journal]
156)  Beaty MW, Quezado M, Sobel ME, Duray P, Merino MJ.
Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.
Int J Surg Pathol. 13: 9-18, 2005.
[Journal]
157)  Palmieri D, Halverson DO, Ouatas T, Horak CE, Salerno M, Johnson J, Figg WD, Hollingshead M, Hursting S, Berrigan D, Steinberg SM, Merino MJ, Steeg PS.
Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
J Natl Cancer Inst. 97: 632-42, 2005.
[Journal]
158)  Wei M, Toure O, Glenn GM, Pithukpakorn M, Neckers L, Stolle C, Choyke P, Grubb R, Middelton L, Turner ML, Walther MM, Merino MJ, Zbar B, Linehan WM, Toro JR.
Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.
J Med Genet. 43: 18-27, 2005.
[Journal]
159)  Li-Ning-T E, Ronchetti R, Torres-Cabala C, Merino MJ.
Role of chromogenic in situ hybridization (CISH) in the evaluation of HER2 status in breast carcinoma: comparison with immunohistochemistry and FISH.
Int. J. Surg. Pathol. 13: 343-51, 2005.
[Journal]
160)  Bates SE, Bakke S, Kang M, Robey RW, Zhai S, Thambi P, Chen CC, Patil S, Smith T, Steinberg SM, Merino M, Goldspiel B, Meadows B, Stein WD, Choyke P, Balis F, Figg WD, Fojo T.
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma.
Clin Cancer Res. 10: 4724-33, 2004.
[Journal]
161)  Lebowitz PF, Eng-Wong J, Swain SM, Berman A, Merino MJ, Chow CK, Venzon D, Zia F, Danforth D, Liu E, Zujewski J.
A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer.
Clin Cancer Res. 10: 6764-9, 2004.
[Journal]
162)  Potlog-Nahari C, Feldman AL, Stratton P, Koziol DE, Segars J, Merino MJ, Nieman LK.
CD10 immunohistochemical staining enhances the histological detection of endometriosis.
Fertil Steril. 82: 86-92, 2004.
[Journal]
163)  Torres-Cabala C, Panizo-Santos A, Krutzsch HC, Barazi H, Namba M, Sakaguchi M, Roberts DD, Merino MJ.
Differential expression of S100C in thyroid lesions.
Int J Surg Pathol. 12: 107-15, 2004.
[Journal]
164)  Schmidt LS, Nickerson ML, Angeloni D, Glenn GM, Walther MM, Albert PS, Warren MB, Choyke PL, Torres-Cabala CA, Merino MJ, Brunet J, Bérez V, Borràs J, Sesia G, Middelton L, Phillips JL, Stolle C, Zbar B, Pautler SE, Linehan WM.
Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene.
J Urol. 172: 1256-61, 2004.
[Journal]
165)  Warren MB, Torres-Cabala CA, Turner ML, Merino MJ, Matrosova VY, Nickerson ML, Ma W, Linehan WM, Zbar B, Schmidt LS.
Expression of Birt-Hogg-Dube gene mRNA in normal and neoplastic human tissues.
Mod Pathol. 17: 998-1011, 2004.
[Journal]
166)  Linehan WM, Vasselli J, Srinivasan R, Walther MM, Merino M, Choyke P, Vocke C, Schmidt L, Isaacs JS, Glenn G, Toro J, Zbar B, Bottaro D, Neckers L.
Genetic basis of cancer of the kidney: disease-specific approaches to therapy.
Clin Cancer Res. 10: 6282S-9S, 2004.
[Journal]
167)  Killian JK, Merino M, Bondy C, Bakalov V, Chow C.
MRI of angiolipoma of the breast in Turner's syndrome.
AJR Am J Roentgenol. 183: 1843-4, 2004.
[Journal]
168)  Ronnett BM, Kajdacsy-Balla A, Gilks CB, Merino MJ, Silva E, Werness BA, Young RH.
Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.
Hum Pathol. 35: 949-60, 2004.
[Journal]
169)  Sanz-Ortega J, Hernández S, Saez MC, Sierra E, Sanz-Ortega G, Torres A, Balibrea JL, Sanz-Esponera J, Merino MJ.
3p21, 5q21, 9p21 and 17p13.1 allelic deletions are potential markers of individuals with a high risk of developing adenocarcinoma in Barrett's epithelium without dysplasia.
Hepatogastroenterology. 50: 404-7, 2003.
[Journal]
170)  Stratton P, Winkel C, Premkumar A, Chow C, Wilson J, Hearns-Stokes R, Heo S, Merino M, Nieman LK.
Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis.
Fertil Steril. 79: 1078-85, 2003.
[Journal]
171)  Toro JR, Glenn G, Hou L, Duray P, Clark B, Merino M, Zbar B, Linehan M, Turner ML.
Facial papules, spontaneous pneumothorax, and renal tumors.
J Am Acad Dermatol. 48: 111-4, 2003.
[Journal]
172)  Palacios J, Sarrió D, García-Macias MC, Bryant B, Sobel ME, Merino MJ.
Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
Mod Pathol. 16: 674-8, 2003.
[Journal]
173)  Gourgiotis L, Sarlis NJ, Reynolds JC, VanWaes C, Merino MJ, Pacak K.
Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-[18F]-fluorodopamine positron emission tomography.
J Clin Endocrinol Metab. 88: 637-41, 2003.
[Journal]
174)  Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML, Stewart L, Duray P, Tourre O, Sharma N, Choyke P, Stratton P, Merino M, Walther MM, Linehan WM, Schmidt LS, Zbar B.
Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.
Am J Hum Genet. 73: 95-106, 2003.
[Journal]
175)  Vasselli JR, Shih JH, Iyengar SR, Maranchie J, Riss J, Worrell R, Torres-Cabala C, Tabios R, Mariotti A, Stearman R, Merino M, Walther MM, Simon R, Klausner RD, Linehan WM.
Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor.
Proc Natl Acad Sci U S A. 100: 6958-63, 2003.
[Journal]
176)  Danforth DN, Cowan K, Altemus R, Merino M, Chow C, Berman A, Chaudhry U, Shriver C, Steinberg SM, Zujewski J.
Preoperative FLAC/granulocyte-colony-stimulating factor chemotherapy for stage II breast cancer: a prospective randomized trial.
Ann Surg Oncol. 10: 635-44, 2003.
[Journal]
177)  Yang JC, Sherry RM, Steinberg SM, Topalian SL, Schwartzentruber DJ, Hwu P, Seipp CA, Rogers-Freezer L, Morton KE, White DE, Liewehr DJ, Merino MJ, Rosenberg SA.
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer.
J Clin Oncol. 21: 3127-32, 2003.
[Journal]
178)  Pak H, Gourgiotis L, Chang WI, Guthrie LC, Skarulis MC, Reynolds JC, Merino MJ, Schrump DS, Libutti SK, Alexander HR, Sarlis NJ.
Role of metastasectomy in the management of thyroid carcinoma: the NIH experience.
J Surg Oncol. 82: 10-8, 2003.
[Journal]
179)  Collins MT, Sarlis NJ, Merino MJ, Monroe J, Crawford SE, Krakoff JA, Guthrie LC, Bonat S, Robey PG, Shenker A.
Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations.
J Clin Endocrinol Metab. 88: 4413-7, 2003.
[Journal]
180)  Abraham J, Bakke S, Rutt A, Meadows B, Merino M, Alexander R, Schrump D, Bartlett D, Choyke P, Robey R, Hung E, Steinberg SM, Bates S, Fojo T.
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Cancer. 94: 2333-43, 2002.
[Journal]
181)  Gillespie JW, Best CJ, Bichsel VE, Cole KA, Greenhut SF, Hewitt SM, Ahram M, Gathright YB, Merino MJ, Strausberg RL, Epstein JI, Hamilton SR, Gannot G, Baibakova GV, Calvert VS, Flaig MJ, Chuaqui RF, Herring JC, Pfeifer J, Petricoin EF, Linehan WM, Duray PH, Bova GS, Emmert-Buck MR.
Evaluation of non-formalin tissue fixation for molecular profiling studies.
Am J Pathol. 160: 449-57, 2002.
[Journal]
182)  Yu J, Steiner FA, Muench JP, Gourgiotis L, Skarulis MC, Altemus RM, Libutti SK, Merino MJ, Sarlis NJ.
Juxtathyroidal neck soft tissue angiosarcoma presenting as an undifferentiated thyroid carcinoma.
Thyroid. 12: 427-32, 2002.
[Journal]
183)  Stratton P, Winkel CA, Sinaii N, Merino MJ, Zimmer C, Nieman LK.
Location, color, size, depth, and volume may predict endometriosis in lesions resected at surgery.
Fertil Steril. 78: 743-9, 2002.
[Journal]
184)  Otis CN, Krebs PA, Albuquerque A, Quezado MM, San Juan X, Sobel ME, Merino MJ.
Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: correlation with related protein products and morphologic features.
Int J Surg Pathol. 10: 237-45, 2002.
[Journal]
185)  McCarthy NJ, Yang X, Linnoila IR, Merino MJ, Hewitt SM, Parr AL, Paik S, Steinberg SM, Hartmann DP, Mourali N, Levine PH, Swain SM.
Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.
Clin Cancer Res. 8: 3857-62, 2002.
[Journal]
186)  Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, Duray P, Merino M, Choyke P, Pavlovich CP, Sharma N, Walther M, Munroe D, Hill R, Maher E, Greenberg C, Lerman MI, Linehan WM, Zbar B, Schmidt LS.
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome.
Cancer Cell. 2: 157-64, 2002.
[Journal]
187)  Wulfkuhle JD, Sgroi DC, Krutzsch H, McLean K, McGarvey K, Knowlton M, Chen S, Shu H, Sahin A, Kurek R, Wallwiener D, Merino MJ, Petricoin EF, Zhao Y, Steeg PS.
Proteomics of human breast ductal carcinoma in situ.
Cancer Res. 62: 6740-9, 2002.
[Journal]
188)  Pavlovich CP, Walther MM, Eyler RA, Hewitt SM, Zbar B, Linehan WM, Merino MJ.
Renal tumors in the Birt-Hogg-Dube syndrome.
Am J Surg Pathol. 26: 1542-52, 2002.
[Journal]
189)  Zbar B, Alvord WG, Glenn G, Turner M, Pavlovich CP, Schmidt L, Walther M, Choyke P, Weirich G, Hewitt SM, Duray P, Gabril F, Greenberg C, Merino MJ, Toro J, Linehan WM.
Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome.
Cancer Epidemiol Biomarkers Prev. 11: 393-400, 2002.
[Journal]
190)  Gourgiotis L, Al-Zubaidi N, Skarulis MC, Papanicolaou DA, Libutti SK, Alexander HR, Merino MJ, Sarlis NJ.
Successful outcome after surgical management in two cases of the.
Endocr Pract. 8: 259-65, 2002.
[Journal]
191)  Danforth DN, Aloj L, Carrasquillo JA, Bacharach SL, Chow C, Zujewski J, Whatley M, Galen B, Merino M, Neumann RD.
The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer.
Breast Cancer Res Treat. 75: 135-46, 2002.
[Journal]
192)  Sanz-Ortega J, Saez MC, Sierra E, Torres A, Balibrea JL, Hernando F, Sanz-Esponera J, Merino MJ.
3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
J Pathol. 195: 429-34, 2001.
[Journal]
193)  Bates S, Kang M, Meadows B, Bakke S, Choyke P, Merino M, Goldspiel B, Chico I, Smith T, Chen C, Robey R, Bergan R, Figg WD, Fojo T.
A Phase I study of infusional vinblastine in combination with the P-glycoprotein antagonist PSC 833 (valspodar).
Cancer. 92: 1577-90, 2001.
[Journal]
194)  Schmidt LS, Warren MB, Nickerson ML, Weirich G, Matrosova V, Toro JR, Turner ML, Duray P, Merino M, Hewitt S, Pavlovich CP, Glenn G, Greenberg CR, Linehan WM, Zbar B.
Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2.
Am J Hum Genet. 69: 876-82, 2001.
[Journal]
195)  Simsir A, Palacios D, Linehan WM, Merino MJ, Abati A.
Detection of loss of heterozygosity at chromosome 3p25-26 in primary and metastatic ovarian clear-cell carcinoma: utilization of microdissection and polymerase chain reaction in archival tissues.
Diagn Cytopathol. 24: 328-32, 2001.
[Journal]
196)  Lawrence JA, Adamson PC, Caruso R, Chow C, Kleiner D, Murphy RF, Venzon DJ, Shovlin M, Noone M, Merino M, Cowan KH, Kaiser M, O'Shaughnessy J, Zujewski J.
Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations.
J Clin Oncol. 19: 2754-63, 2001.
[Journal]
197)  Chico I, Kang MH, Bergan R, Abraham J, Bakke S, Meadows B, Rutt A, Robey R, Choyke P, Merino M, Goldspiel B, Smith T, Steinberg S, Figg WD, Fojo T, Bates S.
Phase I study of infusional paclitaxel in combination with the P-glycoprotein antagonist PSC 833.
J Clin Oncol. 19: 832-42, 2001.
[Journal]
198)  Lei JY, Middleton LP, Guo XD, Duray PH, McWilliams G, Linehan WM, Merino MJ.
Pigmented renal clear cell carcinoma with melanocytic differentiation.
Hum Pathol. 32: 233-6, 2001.
[Journal]
199)  Smallridge RC, Castro MR, Morris JC, Young PR, Reynolds JC, Merino MJ, Sarlis NJ.
Renal metastases from thyroid papillary carcinoma: study of sodium iodide symporter expression.
Thyroid. 11: 795-804, 2001.
[Journal]
200)  Rodrigues RG, Panizo-Santos A, Cashel JA, Krutzsch HC, Merino MJ, Roberts DD.
Semenogelins are ectopically expressed in small cell lung carcinoma.
Clin Cancer Res. 7: 854-60, 2001.
[Journal]
201)  Stratton P, Hartog B, Hajizadeh N, Piquion J, Sutherland D, Merino M, Lee YJ, Nieman LK.
A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women.
Hum Reprod. 15: 1092-9, 2000.
[Journal]
202)  Sanjuan X, Sobel ME, Yang J, Merino MJ.
Alveolar soft part sarcoma: the role of prognostic markers.
Ann Diagn Pathol. 4: 135-42, 2000.
[Journal]
203)  Sanz-Ortega J, Steinberg SM, Moro E, Saez M, Lopez JA, Sierra E, Sanz-Esponera J, Merino MJ.
Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer.
Histol Histopathol. 15: 455-62, 2000.
[Journal]
204)  Kleer CG, Bryant BR, Giordano TJ, Sobel M, Merino MJ.
Genetic Changes in Chromosomes 1p and 17p in Thyroid Cancer Progression.
Endocr Pathol. 11: 137-143, 2000.
[Journal]
205)  Otis CN, Krebs PA, Quezado MM, Albuquerque A, Bryant B, San Juan X, Kleiner D, Sobel ME, Merino MJ.
Loss of heterozygosity in P53, BRCA1, and estrogen receptor genes and correlation to expression of p53 protein in ovarian epithelial tumors of different cell types and biological behavior.
Hum Pathol. 31: 233-8, 2000.
[Journal]
206)  Conley B, O'Shaughnessy J, Prindiville S, Lawrence J, Chow C, Jones E, Merino MJ, Kaiser-Kupfer MI, Caruso RC, Podgor M, Goldspiel B, Venzon D, Danforth D, Wu S, Noone M, Goldstein J, Cowan KH, Zujewski J.
Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer.
J Clin Oncol. 18: 275-83, 2000.
[Journal]
207)  Middleton LP, Palacios DM, Bryant BR, Krebs P, Otis CN, Merino MJ.
Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis.
Am J Surg Pathol. 24: 1650-6, 2000.
[Journal]
208)  Kleer CG, Giordano TJ, Merino MJ.
Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma.
Mod Pathol. 13: 742-6, 2000.
[Journal]
209)  Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, Rehm S, Russo J, Tavassoli FA, Wakefield LM, Ward JM, Green JE.
The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.
Oncogene. 19: 968-88, 2000.
[Journal]
210)  Bertheau P, Steinberg SM, Cowan K, Merino MJ.
Breast cancer in young women: clinicopathologic correlation.
Semin Diagn Pathol. 16: 248-56, 1999.
[Journal]
211)  Zambrano NR, Lubensky IA, Merino MJ, Linehan WM, Walther MM.
Histopathology and molecular genetics of renal tumors toward unification of a classification system.
J. Urol. 162: 1246-58, 1999.
[Journal]
212)  Sanz-Ortega J, Bryant B, Sanz-Esponera J, Asenjo JA, Saez MC, Torres A, Balibrea JL, Sobel ME, Merino MJ.
LOH at the APC/MCC gene (5Q21) is frequent in early stages of non-small cell lung cancer.
Pathol. Res. Pract. 195: 677-80, 1999.
[Journal]
213)  Gnant MF, Berger AC, Huang J, Puhlmann M, Wu PC, Merino MJ, Bartlett DL, Alexander HR, Libutti SK.
Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
Cancer Res. 59: 4668-74, 1999.
[Journal]
214)  Zujewski J, Pai L, Wakefield L, Giusti R, Dorr FA, Flanders C, Caruso R, Kaiser M, Goodman L, Merino M, Gossard M, Noone MA, Denicoff A, Venzon D, Cowan KH, O'Shaughnessy JA.
Tamoxifen and fenretinide in women with metastatic breast cancer.
Breast Cancer Res. Treat. 57: 277-83, 1999.
[Journal]
215)  Krebs PA, Albuquerque A, Quezado M, Bryant B, Sobel ME, Merino MJ, Otis CN.
The use of microsatellite instability in the distinction between synchronous endometrial and colonic adenocarcinomas.
Int. J. Gynecol. Pathol. 18: 320-4, 1999.
[Journal]
216)  Maiman M, Watts DH, Andersen J, Clax P, Merino M, Kendall MA.
Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: a randomized trial.
Obstet. Gynecol. 94: 954-61, 1999.
[Journal]
217)  Sanjuan X, Bryant BR, Sobel ME, Merino MI.
Clonality Analysis of Benign Parathyroid Lesions by Human Androgen Receptor (HUMARA) Gene Assay.
Endocr. Pathol. 9: 293-300, 1998.
[Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 8/4/2014.